Evommune, Inc. (EVMN) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.86x
Evommune, Inc. (EVMN) has a Cash Flow-to-Debt Ratio of -0.86x as of December 2025, meaning its operating cash flow of $-16.70 Million could theoretically repay -1% of its total liabilities ($19.38 Million) in one year. See how financially flexible is Evommune, Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.86x
Operating CF / Total Liabilities
Operating Cash Flow
$-16.70 Million
USD
Total Liabilities
$19.38 Million
USD
Data as of
Dec 2025
Most recent filing
Evommune, Inc. Cash Flow-to-Debt Ratio (2023–2025)
Historical debt coverage capacity for Evommune, Inc. across 3 annual periods. For the full cash flow conversion analysis, see EVMN cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Evommune, Inc. (2023–2025)
Year-by-year debt coverage analysis for Evommune, Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.94x | $-76.44 Million | $19.38 Million | ▼ -1393.1% |
| 2024 | -0.26x | $-58.20 Million | $220.29 Million | ▼ -41.0% |
| 2023 | -0.19x | $-29.97 Million | $159.96 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.